Announcements

Johnson & Johnson Innovation - JJDC, Inc. and Johnson & Johnson filed Amendment No. 1 to Schedule 13G with the SEC on November 6, 2026, disclosing their beneficial ownership of common stock in Contineum Therapeutics, Inc. as of November 3, 2026.

Director James B. Nicholas filed a Form 144 notice of proposed sale of 2,451 shares of Peoples Financial Services Corp common stock, with an approximate sale date of November 6, 2026, as disclosed in a filing submitted that same date.

Greene County Bancorp, Inc. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the three months ended September 30, 2026, and reporting net income of $12,502 thousand, up from $8,870 thousand in the same quarter of the prior …

MGIC Investment Corp officer Paula C. Maggio filed a Form 144 notice of proposed sale of 20,000 shares of common stock, submitted on November 6, 2026, with an aggregate market value of $576,200.00.

TransUnion officer Heather J. Russell filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 10,000 shares of TransUnion common stock with an aggregate market value of $797,120.00.

Joseph A. Alkire, an officer of Kontoor Brands, Inc., filed a Form 144 notice of proposed sale of securities on November 6, 2026, disclosing plans to sell 9,472 shares of common stock through Fidelity Brokerage Services LLC on the NYSE.

USCB Financial Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting third-quarter net income of $9,528 thousand and total assets of $3,011,481 thousand.